Neuregulin can trigger morphogenetic signals in cells both in vivo and in culture through the activation of receptors from the ErbB family. We have ectopically expressed various ErbB-receptors in 32D myeloid cells lacking endogenous ErbB-proteins, and in CHO cells, which express only ErbB-2. We show here that activation of ErbB-3/ErbB-2 heterodimeric receptors triggers PI3-kinase-dependent lamellipodia formation and spreading, while individual ErbB-receptor homodimers as well as ErbB-3/ErbB-1 heterodimers are much less eective. CHO cells expressing ErB-3/ErbB-2 together with Ncadherin, an adhesion receptor, form epithelioid colonies. Neuregulin activates cell motility leading to transition of these colonies into ring-shaped multicellular arrays, similar to those induced by neuregulin in epithelial cells of dierent types . This process requires both PI3-kinase and MAP kinase kinase activity and depends on coordinated changes in the actin-and microtubule-based cytoskeleton. Transactivation of ErbB-2 is not sucient for the activation of cell motility and ring formation, and the C-terminal domain of ErbB-3 bearing the docking sites for the p85 subunit of PI3-kinase is essential for these morphogenetic eects. Thus, ErbB-3 in conjunction with ErbB-2 mediates, via its C-terminal domain, cytoskeletal and adhesion alterations which activate cell spreading and motility, leading to the formation of complex structures such as multicellular rings. Oncogene (2000) 19, 878 ± 888.
Introduction
Morphogenetic processes during embryonic development, are precisely coordinated in time and space (reviewed in Trinkaus, 1984; Edelman et al., 1990; Bray, 1992; Hay, 1995; Gumbiner, 1996) . Soluble ligands (growth factors) were shown to be essential for the control of morphogenesis both in vivo and in vitro. For example, hepatocyte growth factor/scatter factor (HGF/SF), which operates by the activation of its receptor, c-Met (Stoker et al., 1987; Bottaro et al., 1991; Naldini et al., 1991; Gherardi et al., 1993; Jeers et al., 1996) , induces scattering of epithelial colonies grown on two-dimensional substrates in vitro (Stoker et al., 1987; Gherardi et al., 1993) , and formation of branching tubular structures by cells grown in a threedimensional collagen gel (Montesano et al., 1991; Soriano et al., 1995) . Knockout of either HGF/SF or c-Met results in embryonic lethality due to disturbed placenta and liver development and an apparent defect in the migration of muscle precursor cells (Birchmeier et al., 1997) .
Another group of ligands, the neuregulins (also known as NDF, or heregulin) (Burden and Yarden, 1997) are involved in morphogenetic processes including the morphogenesis of heart trabeculae (Meyer and Kramer et al, 1996) , the migration of neural crest cells (Britsch et al., 1998) , and the formation of alveolar structures in mammary gland development (Yang et al., 1995) . All neuregulin isoforms bind directly to the ErbB-3 and ErbB-4 receptors, which cooperate with ErbB-1 (EGF receptor) or the`orphan' ErbB-2 receptor in the generation of a transmembrane signal (Burden and Yarden, 1997; Tzahar and Yarden, 1998) . The ErbB-1 and ErbB-2 coreceptors are essential for ErbB-3-mediated signaling since this receptor has little or no intrinsic tyrosine kinase activity (Guy et al., 1994) .
We have recently shown that stimulation of cultured epithelial cells by neuregulin leads to a unique morphogenetic response, manifested by the formation of ring-shaped multicellular arrays with an internal lumen'. This morphogenetic reaction appeared to depend on neuregulin-mediated stimulation of ErbB-3/ErbB-2 receptor heterodimers .
In the present study we investigated the speci®c roles of ErbB-3 and ErbB-2 in the various manifestations of this morphogenetic response. For this purpose two model systems were used: the ®rst is 32D hematopoietic cells, which lack endogenous ErbB family receptors (Pinkas-Kramarski et al., 1996) . The 32D system enabled us to study the eect of dierent combinations of ErbB receptors on cell attachment, lamellipodia protrusion and spreading. We show here that only the combination of ErbB-2 and ErbB-3 induces signi®cant spreading of 32D cells, which normally grow in suspension.
The formation of more complex morphological structures was investigated in ErbB-3 transfected CHO cells. These cells express endogenous ErbB-2, but no other ErbB family member (Tzahar et al., 1996) . Since CHO cells form only weak intercellular adhesions, we transfected them with N-cadherin cDNA prior to ErbB-3 transfection. The transfected cells form adherens junctions and grow as epithelioid colonies (Levenberg et al., 1998) . The CHO line, expressing a combination of ErbB-2/ErbB-3 and N-cadherin acquired the ability to demonstrate a profound morphogenetic response to neuregulin stimulation, manifested by the formation of multicellular ring-shaped structures. This reaction involved coordinated reorganization of the actin cytoskeleton, focal adhesions, and the microtubular system. We show here that the MAP kinase and PI3-kinase pathways are both required for the process of ring formation, and that the C-terminal part of the ErbB-3 receptor, bearing its major cytoplasmic docking sites, is essential for this morphogenetic response.
Results
ErbB-2/ErbB-3 heterodimers are required for activation of lamellipodial activity and cell spreading in 32D cells
To investigate the role of speci®c ErbB receptors in cellular morphogenesis we used 32D hematopoietic cells, stably transfected with various ErbB receptors. The parental 32D cells do not express any ErbB receptors and fail to spread on glass or plastic surfaces.
Activation of individual receptors of the ErbB-family by their speci®c ligands did not induce signi®cant cell spreading, though in some cases induction of actin containing protrusions was observed. For example, activation of 32D cells transfected with ErbB-1 by EGF (20 ng/ml) enhanced formation of rues on the surface of the spherical cells, and activation of ErbB-2-expressing cells by a speci®c activating antibody (1 ± 10 mg/ml) induced formation of narrow processes in approximately 10% of the cells (not shown) without inducing cell spreading on the substrate. Activation of ErbB-4 by addition of neuregulin also did not induce spreading, although formation of brightly stained actiǹ paracrystals' was noticed (not shown). Addition of neuregulin to 32D cells expressing ErbB-3 did not induce any changes in cell adhesion, morphology or in the actin cytoskeleton (not shown). This absence of a morphogenetic response could be explained by the impaired kinase activity of the ErbB-3 receptor (Guy et al., 1994) .
However, stimulation of 32D cells expressing ErbB-3 together with ErbB-2 (32D-ErbB-2/ErbB-3 line) induces a strong morphogenetic response to neuregulin (Figures 1a, b; 2a, b) manifested by increased lamellipodial activity and formation of numerous actin rich peripheral rues after 20 min of incubation with neuregulin. This process was accompanied by cell adhesion and spreading, leading to a major increase in the projected cell area after 1 h incubation with the ligand. A similar response was obtained after treatment of 32D-ErbB-2/ErbB-3 cells with activating antibodies which engaged either the ErbB-2 (Figure 1d ) or ErbB-3 ( Figure 1e ) receptor subunits, while antibody to ErbB-1 was inactive (Figure 1c) .
ErbB-1 appeared to be much less potent as a coreceptor for ErbB-3 as compared to ErbB-2 in the induction of this morphogenetic response (Figure 2 ). 32D cells co-transfected with ErbB-1 and ErbB-3 (32D-ErbB-1/ErbB-3) exhibited slightly increased ruing after treatment by either EGF or neuregulin, but did Figure 1 ErbB-2/ErbB-3 mediated signaling induces increased lamellipodial activity and spreading in 32D cells. 32D cells stably transfected with both ErbB-2 and ErbB-3 were incubated for 60 min in serum-free medium without additions (a), with 20 ng/ml of neuregulin (b), or with 10 mg/ml of anti ErbB-1 (c), anti-ErbB-2 (d) or anti-ErbB-3 (e) antibodies. Double staining with phalloidin (red) and DAPI (blue). Scale bar, 10 mm. Note signi®cant spreading and formation of actin-rich rues by the cells treated either with neuregulin, or with antibodies to ErbB-2 and ErbB-3 not show a signi®cant increase in the projected cell area (Figure 2d ,e).
Formation of multicellular rings by neuregulin-responsive cells
To study the role of ErbB-2/ErbB-3 receptors in the induction of more complex morphogenesis, we stably transfected ErbB-3 into CHO cells that express chicken N-cadherin. This cell line (clone FL4) forms epithelial islands with cell ± cell adherens junctions and, like wildtype CHO, expresses endogenous ErbB-2, but no other members of the ErbB family (not shown). Stable expression of ErbB-3 in FL4 cells enabled neuregulin binding by these cells (Figure 3) .
Stimulation by neuregulin signi®cantly enhanced cell motility as revealed by the phagokinetic track assay (Figure 3d ± f) . Furthermore, addition of neuregulin to the cell colonies led to a dramatic reorganization of their architecture and formation of ring-shaped multicellular arrays (Figure 4 ). Ring formation was rapid, and within 1.5 ± 2 h of incubation with neuregulin, approximately 90% of colonies consisting of more than four cells, formed rings. The eect required the continuous presence of neuregulin in the medium during the period of ring formation, and the newly formed rings were stable for at least 4 h in the presence of the ligand.
Examination of the ring formation process, using time-lapse video microscopy ( Figure 4 ), indicated that neuregulin induced a major increase in lamellipodial activity at the periphery of the cell colonies. Ruing activity became visible within 5 min of neuregulin treatment and was maximal following 20 ± 30 min of incubation. The increase in ruing was accompanied by rapid spreading of the entire colony, manifested by a twofold increase in its projected area within 60 min of ligand addition.
Usually, within 30 ± 60 min after addition of neuregulin, a gap was formed inside the spreading colony. This gap rapidly increased in size, apparently due to contractions of centrally located cells and their outward movement (Figure 4 ). Ring formation was often accompanied by re-alignment of the peripheral cells: they ®rst moved radially, and then re-oriented themselves tangentially, developing a long axis roughly parallel to the outer edge of the ring (Figure 4 , 60 ± 70 min).
The morphogenetic response of FL4-ErbB-3 cells to neuregulin was dependent on the presence of cadherinmediated cell ± cell adhesions. Disruption of these contacts using a speci®c antibody against the extracellular domain of N-cadherin induced complete scattering of colonies both in the absence and in the presence of neuregulin (not shown).
Neuregulin-induced cytoskeletal reorganization
Fluorescence microscopy revealed that the increase in lamellipodial activity induced by activation of ErbB-3/ ErbB-2 in either 32D (Figure 1 ) or FL4 cells ( Figure  5b ) was accompanied by an increase in the concentra- Figure 2 ErbB-2 is a more potent co-receptor for ErbB-3 than ErbB-1 in induction of lamellipodial activity and spreading. 32D cells transfected with either a combination of ErbB-2 and ErbB-3 (a, b) or ErbB-1 and ErbB-3 (c, d, e) were stimulated with 20 ng/ ml of neuregulin (NDF) (b, e), with 20 ng/ml of EGF (d), or left untreated (a, c) and then processed for scanning electron microscopy. While activation of 32D cells expressing ErbB-2/ErbB-3 by neuregulin induced signi®cant spreading (b), activation of the 32D cells expressing ErbB-1/ErbB-3 by either neuregulin or EGF induced only minor spreading and some ruing activity at the periphery (d, e). All photographs were taken with the same magni®cation, indicated by the scale bar (b) tion of F-actin in the rues and lamellipodia. In nonstimulated colonies of FL4 cells, actin staining was mainly observed along cell ± cell contacts and colocalized with the N-cadherin-rich adhesion belt ( Figure 5a ). Following neuregulin stimulation, adherens junctions were largely preserved, yet they gradually transformed from a continuous belt into an array of streak-like structures, oriented perpendicularly to cell ± cell borders ( Figure 5c ).
Ring formation was also accompanied by signi®cant changes in cell-substrate contacts. Non-stimulated cells displayed small and sparse phosphotyrosine-containing focal contacts, at the periphery of the colonies ( Figure  5g ). Following 20 min of neuregulin treatment, there was a major increase in the number and intensity of these adhesions (Figure 5h ), which progressively developed into mature, elongated focal contacts associated with actin bundles (Figure 5c ,i). Similar changes were observed using anti-vinculin staining (not shown).
Formation of lamellipodia and colony spreading were accompanied by a radial extension of microtubules towards the periphery of the colony; microtubule arrays in mature rings were always oriented outwards (Figure 5d ± f). Centrosomes were also reoriented toward the periphery (Figure 5e ,f). Microtubule reorganization appears to be required for ring formation, since pretreatment of the cells with agents that depolymerize microtubules (nocodazole) or sup- press their dynamics (taxol) hindered this process (Table 1) . Neuregulin-induced lamellipodia formation and colony spreading were inhibited in both the taxoland nocodazole-treated cells. However, nocodazole apparently did not prevent contraction of centrally located cells and formation of gaps in the neuregulintreated colonies; as a result, defective rings with small diameters sometimes appeared even in the presence of this drug (Table 1) .
Thus, formation of actin-rich lamellipodia enhanced by the dynamic microtubular system apparently plays a critical role in neuregulin-induced morphogenesis.
Involvement of the PI3-kinase and MAP kinase pathways in neuregulin-induced morphogenesis
It was recently shown that actin polymerization and formation of lamellipodia depend on PI3-kinase and can be blocked by inhibitors of this signaling enzyme (Kotani et al., 1994; Keely et al., 1997) . Indeed, LY294002, a speci®c inhibitor of PI3-kinase (Vlahos et al., 1994) blocked neuregulin-induced spreading in 32D-ErbB-2/ ErbB-3 cells (Figure 6c,d) , as well as in FL4-ErbB-3 cells stimulated with neuregulin (not shown).
On the other hand, PD98059, an inhibitor of mitogenactivated protein kinase (MAP kinase) pathway (Dudley et al., 1995) which selectively inhibits the MAP kinase activating enzyme, MAP kinase kinase (MEK), and prevents MAP kinase activation by neuregulin ( Figure  6g ), reduced the lamellipodial activity and cell spreading only slightly, if at all (Figure 6e,f) . Nevertheless both LY294002 and PD98059 were highly ecient in preventing the formation of neuregulin-induced rings in FL4-ErbB-3 cells (Table 1) .
The specific role of ErbB-3 in neuregulin-induced morphogenesis ErbB-3 binds neuregulin, but has an impaired kinase activity, while ErbB-2 is an ecient tyrosine kinase, but cannot directly bind neuregulin, or any other known ligand (Burden and Yarden, 1997) . To elucidate the Triple¯uorescence staining of neuregulin-stimulated FL4-ErbB-3 cells with anti-cadherin (green), TRITC-phalloidin (red) and DAPI (blue). Cell ± cell junctions containing both N-cadherin and actin are seen as yellow lines due to superposition of red actin and green cadherin staining. Note numerous actin-containing rues (b) and stress ®bers (c) in the neuregulin-treated cells. Following stimulation, cadherin-containing junctions are converted into the streak-like structures at the border between adjacent cells. Scale bar 8 mm. (d, e, f). Visualization of microtubules using anti-tubulin antibodies (green), centrosomes, using anti-pericentrin antibodies (red), and nuclei (DAPI, blue). Note the neuregulin-induced outward extension of the microtubules, and a shift in the position of the centrosomes towards the periphery of the ring (e, f). Bar, 15 mm. (g, h, i) Visualization of the focal adhesions with anti-phosphotyrosine antibodies. Note numerous dot-like focal contacts formed within 20 min after addition of neuregulin (h), and mature focal adhesions after 60 min of treatment (i). Scale bar, 15 mm speci®c roles of ErbB-3 and ErbB-2 in multicellular ring formation, we transfected FL4 cells with several chimeric and truncated receptors (Figure 7 ). To determine whether ErbB-3 is essential only for ligand binding and transactivation of ErbB-2, or has some additional independent role(s) in the transduction of morphogenetic signals, we have stably expressed in FL4 cells a chimeric receptor (NEC) comprised of the cytoplasmic and transmembrane domains of ErbB-2 and the extracellular domain of the EGF receptor (Peles et al., 1992) . The FL4-NEC cells bound EGF (Figure  8a) , and responded to it by auto-phosphorylation of the NEC receptor, and MAP kinase activation (Figure 8b) . However, no morphogenetic response similar to that induced by neuregulin in FL4-ErbB-3 cells was noted (compare Figure 9b and d) . Moreover, while neuregulin stimulation of FL4-ErbB-3 led to a major increase in cell motility (Figure 3d ± f) , FL4-NEC cells did not undergo a signi®cant change in their lamellipodial activity (Figure 9d) or motility (not shown) following EGF stimulation. These data are in agreement with the absence of strong spreading and lamellipodial activity in stimulated 32D-Erb-2 cells, as described above.
The ErbB-3 receptor is distinct from other ErbB family members in that its C-terminal segment downstream from the impaired tyrosine kinase domain contains unique docking sites that interact with the SH2 domains of various signal transducing proteins. In particular, ErbB-3 is the only ErbB family member that contains six consensus binding sites for the regulatory subunit of PI3-kinase . To test whether these docking sites are involved in the morphogenetic response to neuregulin, FL4 cells were stably transfected with a chimeric receptor, 1T3, which consists of the ErbB-1 (EGF receptor), containing a C-terminus derived from ErbB-3 ( Figure 7 ). As shown in Figure 9h , EGF stimulation of these cells resulted in ring formation. We also expressed in FL4 cells a truncated variant of the ErbB-3 receptor, DCTErbB-3, lacking the C-terminal segment which follows the kinase domain (Figure 7 ). We found that such cells bound neuregulin (Figure 8c ) and underwent MAP kinase activation, similar to cells expressing full-length ErbB-3 (Figure 8d ). However, the signaling via DCTErbB-3 did not induce a morphogenetic response (Figure 9f) , suggesting that the C-terminal domain of the ErbB-3 receptor is essential for neuregulin-induced morphogenetic signaling.
Discussion
In this study we explored the molecular mechanisms involved in neuregulin-induced morphogenesis. We demonstrated that co-expression of the high anity neuregulin receptor ErbB-3 with the`orphan' coreceptor ErbB-2, induced ± upon neuregulin stimulation ± a dramatic increase in adhesion and cell spreading in weakly adherent 32D cells. Neither individual ErbB family receptors, nor co-expression of ErbB-3 with ErbB-1 induced this dramatic response. Moreover, the expression of ErbB-2/ErbB-3 together with the adhesion receptor, N-cadherin, in CHO cells appeared to be both essential and sucient to reconstitute a system demonstrating ring formation, a rather complex morphogenetic behaviour, in response to neuregulin signaling.
The morphogenetic behavior induced by neuregulin in cells expressing ErbB-3/ErbB-2 and N-cadherin, manifested by the formation of organized multicellular structures with an internal lumen, appears to be a process that depends on a temporally and spatially coordinated interplay between cell adhesion and motility. This process can be subdivided into three sequential stages: (1) the rapid activation of polar lamellipodial extensions and cell spreading; (2) outward cell motility without loss of cell ± cell adhesion; and (3) cell contraction and formation of an internal lumen. Ncadherin mediated cell ± cell adhesion is an obvious prerequisite for such morphogenesis, since it is essential for the formation of the epithelioid islands. Consequently, anti-N-cadherin antibodies that blocked the homophilic adhesive interactions induced complete cell scattering rather than ring formation. The driving force for ring formation was an apparent activation of cell motility demonstrated on isolated cells by the phagokinetic track assay.
Thus, formation of ring-shaped colonies following neuregulin stimulation depends on a balance between motility and adhesion. This balance must be accurately regulated to allow sucient locomotory activity to drive cells outwards, yet retain sucient cell ± cell adhesion to prevent complete scattering. Maintenance of such a balance in the system described here, or in epithelial cells at large , appears to be essential characteristics of the morphogenetic response to neuregulin. In contrast, classical scatter factor HGF/SF causes not only strong locomotory stimulus, but also a signi®cant reduction of cell ± cell adhesion (Potempa and Ridley, 1998) resulting in complete scattering of cell colonies in two dimensional culture.
Reorganization of both actin and the microtubule system appear to be important for neuregulin-induced multicellular ring formation. Lamellipodial extension and cell spreading are accompanied, as expected, by Factin enrichment in the lamellipodia and rues. At the same time, a massive and polarized peripheral outgrowth of the microtubules and shift of centrosome positions occurs. At the stage of lumen formation, cell contractility is activated as can be seen from the rapid augmentation of stress ®bers and focal adhesions (Bershadsky et al., 1996; Chrzanowska-Wodnicka and Burridge, 1996) .
Experiments with speci®c inhibitors demonstrate that each of these cytoskeletal events is required for the complete morphogenetic response to neuregulin. In particular, both hyperstabilization of microtubules by taxol or their disruption by nocodazole inhibits neuregulin-induced ring formation by interfering with the ®rst stage of the morphogenetic response, namely the formation of polarized lamellipodia. This is consistent with a number of previous studies demonstrating that dynamic and properly oriented microtubules are essential for polarized formation of lamellipodial extensions (Bershadsky and Vasiliev, 1993; Elbaum et al., 1998) .
We have also demonstrated here that the lamellipodial activity induced by neuregulin critically depends on the activity of PI3-kinase, as was shown previously for several other inducers (Kotani et al., 1994; Adam et al., 1998; Khwaja et al., 1998) . The PI3-kinase inhibitor, LY294002, blocked not only lamellipodia formation and spreading, but also ring formation, con®rming the essential role of lamellipodia activity in this morphogenetic process. The mechanism of PI3-kinase involvement in the induction of lamellipodial activity is still unclear, yet it appears to cooperate with the small GTPases, Rac and Cdc42, and with p21-activated kinase (PAK) in the formation of actin-rich extensions via stimulation of actin polymerization (Reif et al., 1996; Carpenter et al., 1997; Keely et al., 1997; Adam et al., 1998) . There is also evidence for the association of PI3-kinase with microtubules (Kapeller et al., 1995) , and for the involvement of the microtubule system in the outgrowth of cell processes induced by PI3-kinase (Kobayashi et al., 1997; Kita et al., 1998) . Irrespective of the exact mechanism, the involvement of PI3-kinase suggests an essential role for the ErbB-3 receptor, since this receptor is the only member of the ErbB family that contains consensus binding sites for PI3-kinase recruitment.
The mechanism of ErbB-3 involvement in the transduction of morphogenetic signal deserves special discussion. The ErbB-3 receptor is unique in that it is devoid of intrinsic protein kinase activity (Guy et al., 1994; Sierke et al., 1997) . In fact, our experiments with 32D cells expressing ErbB-3 alone showed that this receptor could not itself trigger the morphogenetic response. However, ErbB-3 can be phosphorylated upon ligand-induced heterodimerization of ErbB-3 with either ErbB-1 or ErbB-2 (Solto et al., 1994; Carraway et al., 1995; Kim et al., 1998) . We demonstrated that the combination of ErbB-3 with ErbB-2 was much more potent in the induction of cell spreading than ErbB-3/ErbB-1. ErbB-3 can eciently transactivate the kinase activity of the`orphan' receptor ErbB-2; a speci®c motif, LVI, localized at the impaired kinase domain of ErbB-3 is required for this transactivation (Schaefer et al., 1999) . Truncated ErbB-3 receptors, preserving this LVI motif can transactivate ErbB-2, which in turn leads to phosphorylation of ErbB-3 receptor itself (Schaefer et al., 1999) . In our experiments we observed that the DCT-ErbB-3 receptor, lacking the C-terminal region downstream from the kinase domain but preserving LVI motif, can mediate some signaling eects, in particular, MAP kinase activation. This receptor however was not able Oncogene Mechanism of neuregulin's morphogenetic effect A Chausovsky et al to induce morphogenetic eects, such as cell spreading and ring formation. Thus, transactivation of ErbB-2 and even MAP kinase stimulation is not sucient for morphogenetic eects. We con®rmed this by showing that the direct activation of ErbB-2, using a chimeric receptor that consists of the extracellular region of the EGF receptor and the transmembrane and intracellular domains of ErbB-2 does not product any morphological eects. On the other hand, activation of a chimeric ErbB-1 receptor, bearing an ErbB-3-derived C-terminus (1T3) was shown to induce ring formation in FL4 cells. Thus, one role of transactivation of ErbB-2 is to phosphorylate the C-terminal domain of ErbB-3 thereby creating new docking sites necessary for morphogenetic signaling. Other functions of ErbB-2 cannot be excluded, however, since 1T3 transfection of 32D cells (lacking endogenous ErbB-2) was insucient to induce morphological changes in response to EGF (our unpublished results).
Among the docking sites uniquely present on the Cterminal tail of ErbB-3 are the docking sites for the p85 subunit of PI3 kinase. The amino acid sequence motif (phospho)Tyr-X 1 -X 2 -Met (pYXXM), has been shown to speci®cally associate with the SH2 domains of p85, the PI3-kinase regulatory subunit (McGlade et al., 1992; Prigent and Gullick, 1994) . The C-terminus of ErbB-3 contains six YXXM sites and several of these are spaced suitably to permit tandem binding of two SH2 domains of p85, while others may also cooperate in p85 binding . These structural features make ErbB-3 particularly potent in the signalinduced activation of PI3-kinase .
The essential role of PI3-kinase explains why activation of MAP kinase is not sucient for the complete morphogenetic response. Moreover, an inhibitor of the MAP kinase pathway, PD98059, did not interfere with lamellipodia formation and cell spreading. This inhibitor, however, still prevented the assembly of the ring-shaped structures. The role of MAP kinase signaling therefore appears to be important in the events following the induction of spreading. Several recent studies demonstrated the involvement of the MAP kinase pathway in various aspects of cell motility (Klemke et al., 1997; Khwaja et al., 1998) . Moreover, it was shown recently that neuregulin-induced alveolar morphogenesis in Matrigel-based 3-D culture system was inhibited by PD98059 (Niemann et al., 1998) . The possible function of MAP kinase signaling in the organization of multicellular rings requires further investigation.
Based on our studies, a likely scenario for the neuregulin-induced morphogenetic response includes the following events: (a) neuregulin stimulation of ErbB-3/ErbB-2 dimer formation and transactivation of ErbB-2; (b) ErbB-2-mediated phosphorylation of speci®c tyrosine residues at the C-terminus of the ErbB-3, including consensus sites for PI3-kinase binding; (c) PI3-kinase recruitment (and probably recruitment of other downstream elements) and triggering of actin-and microtubule-dependent activation of lamellipodial extension and cell spreading, without concomitant disruption of the adherents junctions; (d) MAP-kinase-dependent outward cell movement and contraction, to convert cell colonies into multicellular rings containing a lumen-like gap.
Thus, ErbB-3/ErbB-2 receptor dimers appear to mediate the neuregulin-induced morphogenetic signal by coordinate activation of both the PI3-kinase and MAP kinase pathways. Further studies are necessary to elucidate the interplay between the signaling events and the subsequent changes in the cytoskeletal machinery, which are responsible for the performing of this simpli®ed but instructive morphogenetic process.
Materials and methods
Cell culture, transfections, and ligand treatment Sublines of the 32D murine hematopoietic progenitor cell line (Greenberger et al., 1983 ) that express various ErbB-proteins were established through a two-step transfection protocol with ErbB-expression vectors, as described (Pinkas- Kramarski et al., 1996) . Both the original 32D cells and their stable transfectants were routinely cultivated in RPMI medium supplemented with antibiotics, 10% heat-inactivated fetal bovine serum and 0.1% medium that was conditioned by IL-3-producing cells. 32D cells do not attach and spread on tissue culture dishes or on glass coverslips. Preliminary experiments showed that binuclear cells are much more sensitive to stimulants inducing attachment and spreading as compared to mononuclear cells, therefore binuclear cells were obtained by pretreatment with cytochalasin D, which interferes with cytokinesis, but does not aect nuclear division. The cells were preincubated in growth medium containing 0.3 mg/ml cytochalasin D for 16 h before each experiment. After this preincubation, about 90% of the cells were binuclear. The cells were then washed twice and incubated in serum-free medium without cytochalasin D for 1 h. The various ligands (see below) were added to the cultures for 1 h and the cells ®xed.
To produce cells expressing both N-cadherin and either ErbB-3, or chimeric or truncated receptors, the FL4 subline was used (Levenberg et al., 1998) . These cells were produced by transfection of wild-type CHO cells with a vector encoding chicken N-cadherin. FL4 cells were stably co-transfected with the PCDNA-3 expression vectors containing ErbB-3, DCTErbB-3, 1T3 or NEC c-DNA together with a puromycinresistance gene. NEC is a chimeric receptor consisting of the extracellular part of the EGF receptor (ErbB-1) and the transmembrane and cytoplasmic portions of the Neu (ErbB-2) receptor (Peles et al., 1992) . DCT-ErbB-3 receptor is a deletion mutant of ErbB-3, lacking the C-terminal cytoplasmic region, immediately downstream of the tyrosine kinase domain. The 1T3 chimeric receptor consists of the ErbB-1 receptor with its C-terminal region exchanged for that of ErbB-3 receptor. The various chimeric constructs used are schematically depicted in Figure 7 . Cells were cultured as previously described (Sliwkowski et al., 1994) .
For microscopic observations of FL4 cell derivatives, 5610 4 cells were plated on 18 mm coverslips, maintained for 24 h in DMEM with 10% bovine calf serum, washed once with serum-free DMEM and incubated for an additional 24 h. At that time, compact cell colonies were formed. Neuregulin (20 ng/ml) or EGF (20 ng/ml) was added in serum-free DMEM for an additional 1 ± 3 h. Experiments with 1T3 cells were performed in DMEM containing 1% bovine calf serum. Recombinant rat neuregulin (NDF b4) expressed in CHO cells (Amgen Co, USA) was used in all experiments. EGF was purchased from Sigma Israel (Cat. No E-1257) . Antibodies against ErbB-1, ErbB-2, and ErbB-3 were described previously (Pinkas-Kramarski et al., 1996) . The PI3-kinase inhibitor LY294002 and the MAP kinase kinase (MEK) inhibitor PD98059 (Calbiochem, La Jolla, CA, USA) were used at a ®nal concentration of 25 and 100 mM respectively. Taxol (paclitaxel) and nocodazole (methyl-[5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl] carbamate) obtained from Sigma Israel were used at a ®nal concentration 20 mM (taxol) and 10 mM (nocodazole).
Biochemical and immunochemical procedures
Immunoprecipitation and Western blotting were performed as previously described (Bershadsky et al., 1996) . Anti-ErbB-1 (Tzahar et al., 1996) , anti-PY (PT-66, Sigma, Israel), or anti-activated MAP kinase (Gabay et al., 1997 ; kindly provided by Dr Rony Seger, Weizmann Institute of Science), were used as primary antibodies. The secondary antibody used was horseradish peroxidase-labeled anti-mouse IgG (Amersham, UK). Radiolabeling of ligands, covalent crosslinking and ligand binding assays were done according to Tzahar et al. (1996) . In all experiments the protein loading was controlled by the staining of the same blots with the antia-tubulin antibody (clone DM-1A, Sigma, Israel).
Microscopy and immunofluorescence
For light microscopic examination of living cells, the cells were plated and cultured overnight in serum-containing DMEM and for 24 h in serum-free DMEM. The medium was changed to serum-free L15 medium for 1 h. The dish was then transferred to an inverted microscope (Zeiss Axiovert 35) equipped with DIC optics and red light illumination. The objective (Zeiss Fluar 10061.3) was maintained at 378C by a regulated electric heater (Bioptechs Ltd, USA). Images were taken with a CCD video camera (iSight, Israel) and recorded on S-VHS cassettes.
Immuno¯uorescence staining was performed as described (Bershadsky et al., 1996) . The following primary antibodies were used: rabbit anti-pan cadherin (C3678, Sigma, Israel), monoclonal anti-phosphotyrosine (clone PT66, Sigma, Israel), monoclonal anti-a tubulin (clone DM1A, Sigma, Israel), and rabbit anti-pericentrin (kindly provided by Dr SJ Doxey, University of Massachusetts, USA). FITC-or TRITC-labeled goat antibodies to mouse and rabbit immunoglobulins (Jackson Laboratories, West Grove, PA, USA) were used as secondary antibodies. Actin was stained with FITC-or TRITC-labeled phalloidin (Sigma, Israel) and nuclei were stained with DAPI. The specimens were examined by¯uorescence microscopy using a Zeiss Axiophot microscope (Zeiss, Germany) equipped with a 10061.3 Planapochromat objective, a CCD camera (Photometrics, USA), and the Priism software package (Applied Precision, Issaquah, WA, USA) on a Silicon Graphics computer. The Priism software was used for superposition of triple labeling onto a single color picture. Scanning electron microscopy was performed as described previously (Levenberg et al., 1998) .
Cell motility measurements
To assess the rate of cell motility, the phagokinetic track method was used (Albrech-Buehler, 1977) . Cells were seeded on 18 mm coverslips coated with colloidal gold at a density of 2610 3 per coverslip and incubated for 4 h. The medium was then changed to serum-free medium, with or without b4 NDF (20 ng/ml), and the cells were incubated overnight (20 h). Tracks were examined by dark ®eld microscopy using a 106 objective. The areas of 40 ± 50 randomly selected tracks were measured for each determination.
